COMMENT Ozempic compensating for Wegovy’s supply shortage due to high demand Manufacturing challenges set back progress of cell therapies in oncology Chinese manufacturers’ transition to innovative pharma needs more investment DLBCL: a rapidly evolving treatment landscape with a crowded pipeline R&D Cannabinoids receptors: popular preclinical target but banned in 137 countries Cannabinoid receptors are currently the most popular targets for CNS in preclinical development, with 391 drugs tagged in total insight Europe reports the highest prevalence of chronic cough comment Could vaccine hesitancy impact hearing disorders? Ozempic compensating for Wegovy’s supply shortage due to high demand Manufacturing challenges set back progress of cell therapies in oncology Chinese manufacturers’ transition to innovative pharma needs more investment DLBCL: a rapidly evolving treatment landscape with a crowded pipeline 02/23/2024 23:26:12
Ozempic compensating for Wegovy’s supply shortage due to high demand
Manufacturing challenges set back progress of cell therapies in oncology
Chinese manufacturers’ transition to innovative pharma needs more investment
DLBCL: a rapidly evolving treatment landscape with a crowded pipeline